Iovance Biotherapeutics
IOVA
IOVA
87 hedge funds and large institutions have $461M invested in Iovance Biotherapeutics in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 85 → 87 (+2)
2.27% more ownership
Funds ownership: 77.09% → 79.36% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
87
Holding in Top 10
2
Calls
$942K
Puts
$345K
Top Buyers
| 1 | +$8.42M | |
| 2 | +$8.17M | |
| 3 | +$8.14M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.16M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.68M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$7.02M | |
| 3 | -$5.22M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$4.3M |
| 5 |
JPMorgan Chase & Co
New York
|
-$4.12M |